investors who bought stocks during the covid19 market crash in 2020 have generally experienced some big gains in the past two years but there is no question some bigname stocks performed better than others since the pandemic bottom pfizers bumpy ride one company that has been a lackluster investment in the past two years has been pharmaceutical giant pfizer inc pfe pfizer investors have likely been extremely disappointed with the performance of the stock in the past year given how much attention the company’s covid19 vaccine has gotten beyond the vaccine thesis pfizer’s 6 compound annual revenue growth guidance through 2025 isn’t the type of highflying growth numbers that get investors particularly excited about a stock even after spinning off its generic and offpatent branded drug business pfizer is still more of a value stock than a growth stock at the beginning of 2020 pfizer shares were trading at around 37 by the beginning of march the stock was down to 3359 after news of the coronavirus spreading in china prompted concerns about a us pandemic pfizer bottomed at 2788 during the pandemicdriven march selloff fortunately for pfizer investors the dip did not last long by late april pfizer shares were back near 40 on vaccine optimism however the stock stalled there while pfizer and other competitors raced to win the vaccine testing and approval race pfizer shares jumped to 4199 on massive volume in november 2020 when the company announced its covid19 vaccine was more than 90 effective in latestage trials related link if you invested 1000 in moderna stock at its pandemic low heres how much youd have now pfizer in 2022 beyond the stock hit 4308 in december 2020 when pfizer’s vaccine was the first candidate to officially get the green light from the fda pfizer shares eventually made it as high as 6171 in december 2021 after vaccine approvals were expanded before pulling all the way back to 4934 today still investors who bought pfizer on the day it hit its 2020 pandemic low and held on have generated a solid overall return on their investment in fact 1000 in pfizer stock bought on march 23 2020 would be worth about 1993 today assuming reinvested dividends looking ahead analysts are expecting pfizers stock to continue to grid higher in the next 12 months the average price target among the 20 analysts covering the stock is 57 suggesting a 155 upside from current levels